Hidradenitis Suppurativa (HS) - The Dermatology Digest

FDA Accepts sBLA for UCB’s Bimzelx in Moderate-to-Severe HS and Additional 2mL Device Presentations

April 4, 2024

News You Can Use: AARS Now Accepting Applications for Research Grant Awards

March 13, 2024

Topical JAK Shows Promise in Milder HS

March 12, 2024

Novartis’ BTK Inhibitor Outpaces Placebo in HS Trial

March 9, 2024

HS Pipeline Watch: MoonLake Immunotherapeutics’ Sonelokimab Heads to Phase 3

February 26, 2024

Latest Issue

Latest Supplements

Digital Edition Archive